FDA Advisers Endorse Pfizer Booster Shots For Elderly And High-Risk Americans
After overwhelmingly rejecting a plan to give Pfizer booster shots against COVID-19 to most Americans, an influential federal advisory panel has approved the extra shots for those who are 65 or older or run a high risk of severe disease.